GSK announces positive results from GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus (relentless itch) associated with PBC: London, UK Wednesday, Novembe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback